Astaxanthin protects against oxidative stress and calcium-induced porcine lens protein degradation

Journal of Agricultural and Food Chemistry

Volumn 54, Issue 6, 2006, Pages 2418-2423

  Wu, Tzu Hua ^a   Liao, Jiahn Haur ^b   Hou, Wen Chi ^a   Huang, Fu Yung ^c   Maher, Timothy J ^d   Hu, Chao Chien ^e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Astaxanthin; Calcium complex; Calcium induced turbidity; Lens proteins; Oxidative stress

Indexed keywords

ALGAE; SUIDAE;

ASTAXANTHIN; BETA CAROTENE; CALCIUM; CALPAIN; CRYSTALLIN; DRUG DERIVATIVE; HYDROXYL RADICAL; XANTHOPHYLL;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG INTERACTION; ENZYME ACTIVATION; METABOLISM; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; SWINE;

ANIMALS; BETA CAROTENE; CALCIUM; CALPAIN; CRYSTALLINS; DRUG INTERACTIONS; ENZYME ACTIVATION; HYDROXYL RADICAL; OXIDATION-REDUCTION; OXIDATIVE STRESS; SWINE; XANTHOPHYLLS;

EID: 33645782299     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf052651q     Document Type: Article

References (59)

1. Head, K. A. Natural therapies for ocular disorders, part two: Cataracts and glaucoma. Altern. Med. Rev. 2001, 6, 141-166.
2. Taylor, A.; Jacques, P. F.; Chylack, L. T., Jr.; Hankinson, S. E.; Khu, P. M.; Rogers, G.; Friend, J.; Tung, W.; Wolfe, J. K.; Padhye, N.; Willett, W. C. Long-term intake of vitamins and carotenoids and odds of early age-related cortical and posterior subcapsular lens opacities. Am. J. Clin. Nutr. 2002, 75, 540-549.
3. Trevithick, J. R.; Mitton, K. P. Vitamins C and E in cataract risk reduction. Int. Ophthalmol. Clin. 2000, 40, 59-69.
4. Kilic, F.; Trevithick, J. R. Vitamin C reduces cytochalasin D cataractogenesis. Curr. Eye Res. 1995, 14, 943-949.
5. Jacques, P. F.; Chylack, L. T., Jr.; Hankinson, S. E.; Khu, P. M.; Rogers, G.; Friend, J.; Tung, W.; Wolfe, J. K.; Padhye, N.; Willett, W. C.; Taylor, A. Long-term nutrient intake and early age-related nuclear lens opacities. Arch. Ophthalmol. 2001, 119, 1009-1019.
6. Bone, R. A.; Landrum, J. T.; Fernandez, L.; Tarsis, S. L. Analysis of the macular pigment by HPLC: Retinal distribution and age study. Invest. Ophthalmol. Vis. Sci. 1988, 29, 843-849.
7. Brown, L.; Rimm, E. B.; Seddon, J. M.; Giovannucci, E. L.; Chasan-Taber, L.; Spiegelman, D.; Willett, W. C.; Hankinson, S. E. A prospective study of carotenoid intake and risk of cataract extraction in US men. Am. J. Clin. Nutr. 1999, 70, 517-524.
8. Chasan-Taber, L.; Willett, W. C.; Seddon, J. M.; Stampfer, M. J.; Rosner, B.; Colditz, G. A.; Speizer, F. E.; Hankinson, S. E. A prospective study of carotenoid and vitamin A intakes and risk of cataract extraction in US women. Am. J. Clin. Nutr. 1999, 70, 509-516
9. Lyle, B. J.; Mares-Perlman, J. A.; Klein, B. E.; Klein, R.; Greger, J. L. Antioxidant intake and risk of incident age-related nuclear cataracts in the Beaver Dam Eye Study. Am. J. Epidemiol. 1999, 149, 801-809.
10. Yeum, K. J.; Taylor, A.; Tang, G.; Russell, R. M. Measurement of carotenoids, retinoids, and tocopherols in human lenses. Invest. Ophthalmol. Vis. Sci. 1995, 36, 2756-2761.
11. Yeum, K. J.; Shang, F. M.; Schalch, W. M.; Russell, R. M.; Taylor, A. Fat-soluble nutrient concentrations in different layers of human cataractous lens. Curr. Eye Res. 1999, 19, 502-505.
12. Bernstein, P. S.; Khachik, F.; Carvalho, L. S.; Muir, G. J.; Zhao, D. Y.; Katz, N. B. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp. Eye Res. 2001, 72, 215-223.
13. Miki, W.; Yamaguchi, K.; Konosu, S. Comparison of carotenoids in the ovaries of marine fish and shellfish. Comp. Biochem. Physiol. B 1982, 71, 7-11.
14. Ohgami, K.; Shiratori, K.; Kotake, S.; Nishida, T.; Mizuki, N.; Yazawa, K.; Ohno, S. Effects of astaxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Invest. Ophthalmol. Vis. Sci. 2003, 44, 2694-2701.
15. Guerin, M.; Huntley, M. E.; Olaizola, M. Haematococcus astaxanthin: Applications for human health and nutrition. Trends Biotechnol. 2003, 21, 210-216.
16. Naguib, Y. M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48, 1150-1154.
17. Palozza, P.; Krinsky, N. I. Astaxanthin and canthaxanthin are potent antioxidants in a membrane model. Arch. Biochem. Biophys. 1992, 297, 291-295.
18. Terao, J. Antioxidant activity of beta-carotene-related carotenoids in solution. Lipids 1989, 24, 659-661.
19. Kang, J. O.; Kim, S. J.; Kim, H. Effect of astaxanthin on the hepatotoxicity, lipid peroxidation and antioxidative enzymes in the liver of CC14-treated rats. Methods Find Exp. Clin. Pharmacol. 2001, 23, 79-84.
20. Jyonouchi, H.; Sun, S.; Iijima, K.; Gross, M. D. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer 2000, 36, 59-65.
21. Wang, X.; Willen, R.; Wadstrom, T. Astaxanthin-rich algal meal and vitamin C inhibit Helicobacter pylori infection in BALB/cA mice. Antimicrob. Agents Chemother. 2000, 44, 2452-2457.
22. Bennedsen, M.; Wang, X.; Willen, R.; Wadstrom, T.; Andersen, L. P. Treatment of H. pylori infected mice with antioxidant astaxanthin reduces gastric inflammation, bacterial load and modulates cytokine release by splenocytes. Immunol. Lett. 1999, 70, 185-189.
23. Waagbo, R.; Hamre, K.; Bjerkas, E.; Berge, R.; Wathne, E.; Lie, O.; Torstensen, B. Cataract formation in Atlantic salmon, Salmo salar L. smolt relative to dietary pro- and antioxidants and lipid level. J. Fish Dis. 2003, 26, 213-229.
24. Sheridan, E. J.; Zigman, S. Fate of human lens soluble protein during cataractogenesis. Exp. Eye Res. 1971, 12, 33-38.
25. Jedziniak, J. A.; Kinoshita, J. H.; Yates, E. M.; Hocker, L. O.; Benedek, G. B. Calcium-induced aggregation of bovine lens alpha crystalline. Invest. Ophthalmol. 1972, 11, 905-915.
26. Horwitz, J. Proctor Lecture. The function of alpha-crystallin. Invest. Ophthalmol. Vis. Sci. 1993, 34, 10-22.
27. Groenen, P. J.; Merck, K. B.; de Jong, W. W.; Bloemendal, H. Structure and modifications of the junior chaperone alpha-crystallin. From lens transparency to molecular pathology. Eur. J. Biochem. 1994, 225, 1-19.
28. Liao, J. H.; Hung, C. C.; Lee, J. S.; Wu, S. H.; Chiou, S. H. Characterization, cloning, and expression of porcine alpha B crystallin. Biochem. Biophys. Res. Commun. 1998, 244, 131-137.
29. Garner, B.; Davies, M. J.; Truscott, R. J. Formation of hydroxyl radicals in the human lens is related to the severity of nuclear cataract. Exp. Eye Res. 2000, 70, 81-88.
30. Kramar, P.; Harris, C.; Guy, A. W. Thermal cataract formation in rabbits. Bioelectromagnetics 1987, 8, 397-406.
31. Mohan, M.; Sharma, Y. R.; Vajpayee, R. B.; Bhatnagar, R.; Azad, R. V.; Mukesh, K. Clinical evidence for light-induced thermal damage in cortical cataracts. Dev. Ophthalmol. 1989, 17, 114-117.
32. Cammarata, P. R.; Zhou, C.; Chen, G.; Singh, I.; Reeves, R. E.; Kuszak, J. R.; Robinson, M. L. A transgenic animal model of osmotic cataract. Part 1: Overexpression of bovine Na+/myoinositol cotransporter in lens fibers. Invest. Ophthalmol. Vis. Sci. 1999, 40, 1727-1737.
33. Rosen, N.; Godel, V.; Lazar, M. Cataracts due to repeated osmotic insults. Ophthalmologica 1981, 183, 187-189.
34. Ayala, M. N.; Michael, R.; Soderberg, P. G. Influence of exposure time for UV radiation-induced cataract. Invest. Ophthalmol. Vis. Sci. 2000, 41, 3539-3543.
35. West, S. Ocular ultraviolet B exposure and lens opacities: A review. J. Epidemiol. 1999, 9, S97-S101.
36. Liao, J. H.; Lee, J. S.; Chiou, S. H. Distinct roles of alphaA- and alphaB-crystallins under thermal and UV stresses. Biochem. Biophys. Res. Commun. 2002, 295, 854-861.
37. Goldstein, L. E.; Leopold, M. C.; Huang, X.; Atwood, C. S.; Saunders, A. J.; Hartshorn, M.; Lim, J. T.; Faget, K. Y.; Muffat, J. A.; Scarpa, R. C.; Chylack, L. T., Jr.; Bowden, E. F.; Tanzi, R. E.; Bush, A. I. 3-Hydroxykynurenine and 3-hydroxyanthranilic acid generate hydrogen peroxide and promote alpha-crystallin cross-linking by metal ion reduction. Biochemistry 2000, 39, 7266-7275.
38. Smith, J. B.; Jiang, X.; Abraham, E. C. Identification of hydrogen peroxide oxidation sites of alpha A- and alpha B-crystallins. Free Radical Res. 1997, 26, 103-111.
39. Willis, J. A.; Schleich, T. Oxidative-stress induced protein glutathione mixed-disulfide formation in the ocular lens. Biochim. Biophys. Acta 1996, 1313, 20-28.
40. Wang, K.; Spector, A. Alpha-crystallin can act as a chaperone under conditions of oxidative stress. Invest. Ophthalmol. Vis. Sci. 1995, 36, 311-321.
41. Hanson, S. R.; Chen, A. A.; Smith, J. B.; Lou, M. F. Thiolation of the gammaB-crystalline in intact bovine lens exposed to hydrogen peroxide. J. Biol. Chem. 1999, 274, 4735-4742.
42. Qian, W.; Shichi, H. Naphthoquinone-Induced cataract in mice: Possible involvement of Ca2+ release and calpain activation. J. Ocul. Pharmacol. Ther. 2001, 17, 383-392.
43. Duncan, G.; Bushell, A. R. Ion analyses of human cataractous lenses. Exp. Eye Res. 1975, 20, 223-230.
44. David, L. L.; Shearer, T. R. Calcium-activated proteolysis in the lens nucleus during selenite cataractogenesis. Invest. Ophthalmol. Vis. Sci. 1984, 25, 1275-1283.
45. Chitchumroonchokchai, C.; Bomser, J. A.; Glamm, J. E.; Failla, M. L. Xanthophylls and alpha-tocopherol decrease UVB-induced lipid peroxidation and stress signaling in human lens epithelial cells. J. Nutr. 2004, 134, 3225-3232.
46. Guptasarma, P.; Balasubramanian, D.; Matsugo, S.; Saito, I. Hydroxyl radical mediated damage to proteins, with special reference to the crystalline. Biochemistry 1992, 31, 4296-4303.
47. Biswas, S.; Harris, F.; Singh, J.; Phoenix, D. A. The in vitro retardation of porcine cataractogenesis by the calpain inhibitor, SJA6017. Mol. Cell Biochem. 2004, 261, 169-173.
48. Huang, F. Y.; Chia, C. M.; Ho, Y. The formation of oxidatively induced high-molecular-weight aggregate of alpha-/gamma-crystallins. Biochem. Biophys. Res. Commun. 1999, 260, 60-65.
49. Nakamura, Y.; Fukiage, C.; Azuma, M.; Shearer, T. R. Oxidation enhances calpain-induced turbidity in young rat lenses. Curr. Eye Res. 1999, 19, 33-40.
50. Yokoyama, A.; Adachi, K.; Shizuri, Y. New carotenoid glucosides, astaxanthin glucoside and adonixanthin glucoside, isolated from the astaxanthin-producing marine bacterium, Agrobacterium aurantiacum. J. Nat. Prod. 1995, 58, 1929-1933.
51. Monder, C.; Iohan, F.; Marandici, A. Corticosteroid-calcium complexes. Steroids 1988, 52, 15-36.
52. Yamano, Y.; Sato, Y.; Watanabe, Y.; Namikawa, K.; Miki, Y.; Ito, M. Carotenoids and related polyenes. Part 6. Stereoselective synthesis of astaxanthin analogues and their antioxidant activities. J. Chem. Soc., Perkin Trans. 2001, 1, 1862-1869.
53. Garland, D.; Zigler, J. S., Jr.; Kinoshita, J. Structural changes in bovine lens crystallins induced by ascorbate, metal, and oxygen. Arch. Biochem. Biophys. 1986, 251, 771-776.
54. Bando, M.; Obazawa, H. Calcium-induced opacification of rat lens beta-crystallin solution: Its susceptibility to H2O2 oxidation. Jpn. J. Ophthalmol. 1989, 33, 204-211.
55. David, L. L.; Wright, J. W.; Shearer, T. R. Calpain II induced insolubilization of lens beta-crystallin polypeptides may induce cataract. Biochim. Biophys. Acta 1992, 1139, 210-216.
56. Manzanares, D.; Bauby, C.; de la Pena, R.; Garcia, J. C.; Sanchez, R.; Martinez, S.; Romay, C. H.; Lopez-Reconde, J. L.; Pino, E.; Lissi, E. A. Antioxidant properties of alpha-crystallin. J. Protein Chem. 2001, 20, 181-189.
57. Xu, W.; Yao, K.; Wang, K.; Shentu, X.; Qiu, P. [The expression of calpain II in rat lens epithelial cells of hydrogen peroxide-induced cataract]. Zhonghua Yan Ke Za Zhi 2002, 38, 282-285.
58. Kelley, M. J.; David, L. L.; Iwasaki, N.; Wright, J.; Shearer, T. R. alpha-Crystallin chaperone activity is reduced by calpain II in vitro and in selenite cataract. J. Biol. Chem. 1993, 268, 18844-18849.
59. Spiller, G. A.; Dewell, A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: A randomized clinical trial. J. Med. Food 2003, 6, 51-56.